Houlihan Lokey (HLI) Q1 2027 Earnings Call Transcript

Houlihan Lokey reported Q1 FY2027 revenue of $511M (down 15.5% y/y from $605M) and adjusted diluted EPS of $1.35 (vs. $2.14), with Corporate Finance revenue down 24% to $303M as average M&A fees fell despite deal count holding at 127. The firm’s Financial and Valuation Advisory revenue rose 13% to $89M, and Financial Restructuring revenue was $119M (down 8%) amid extended transaction timelines driven by Middle East geopolitical uncertainty and software/valuation repricing. Management said the impact is a “rain delay” rather than a reset, backed by record Corporate Finance backlog, and reiterated an FY2027 adjusted effective tax rate of 26%–28% alongside the expected end-of-Q2 close of its Intrepid Financial Partners acquisition (adding 32 energy-sector colleagues).

Analysis

The key market issue is not the size of the revenue miss; it is the asymmetry between HLI’s fixed-cost model and a deal cycle that is increasingly K-shaped. Large-cap advisory is still functioning, but HLI’s heavier exposure to sponsor-led mid-market processes and European softness leaves it more levered to timing slippage than GS/MS, so the next 1-2 quarters should remain noisy even if the underlying backlog is intact. That means near-term multiple risk is real: the market will likely punish any sign that delayed closings are migrating from “timing” to “repricing.”

Second-order, the mix shift matters more than the headline decline. When larger fee deals slip, the firm is left with lower-margin advisory work while comp stays effectively fixed, which caps operating leverage upside until the backlog converts. The good news is that the pain in software and distressed energy is not just a drag; it is also a pipeline creator for restructuring over the next 6-18 months, and the Intrepid/energy move plus data/benchmark efforts should modestly widen the moat versus smaller boutiques that cannot fund tech or sector specialization.

Contrarian view: consensus may be too focused on the revenue miss and not enough on the fact that HLI is gaining structural share from boutiques, which should show up first in wins, then in fees with a lag. But the burden of proof is on execution: if June/July improvement does not translate into a visible Q2 close-rate rebound, the “rain delay” narrative will start to look like a cycle reset rather than postponement.

Key Decisions for Investors

• Relative value: short HLI / long GS or MS for 1-3 months. Thesis: large-cap M&A is healthier than mid-cap, so the public bulge-bracket complex should outperform if the cycle remains bifurcated. Cover if HLI shows a material close-rate rebound next quarter.
• Do not buy HLI aggressively on the first print; wait for confirmation that delayed transactions are converting. Use the next 30-45 days as a watch window, and only get constructive if Corporate Finance revenue inflects with improving average fees, not just stable volume.
• If you want exposure to the restructuring second-order, prefer a basket long in credit-stressed beneficiaries over HLI outright. HLI has the right pipeline, but the monetization lag means the equity may not capture the upside until 2H26/2027.
• Use any 5-8% rally in HLI to trim rather than chase. Falsifier for the bearish near-term view: a clear improvement in mid-market close rates and sponsor activity by the next earnings call; absent that, downside from margin compression outweighs the upside from backlog.